Prostate cancer post-treatment follow-up and recurrence evaluation
| Autor: | Adam T. Froemming, Lyndsay D. Viers, Eric J. May, Boyd R. Viers, Akira Kawashima, Eugene D. Kwon, R. Jeffrey Karnes |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Male
Oncology Biochemical recurrence medicine.medical_specialty Urology Population 030232 urology & nephrology Contrast Media Disease 03 medical and health sciences Prostate cancer 0302 clinical medicine Risk Factors Positron Emission Tomography Computed Tomography Internal medicine medicine Humans Radiology Nuclear Medicine and imaging education Neoplasm Staging education.field_of_study Radiological and Ultrasound Technology business.industry Gastroenterology Prostatic Neoplasms Pet imaging Hepatology medicine.disease Magnetic Resonance Imaging Lymphatic Metastasis 030220 oncology & carcinogenesis Recurrent prostate cancer Neoplasm Recurrence Local Radiopharmaceuticals Post treatment business |
| Zdroj: | Abdominal Radiology. 41:862-876 |
| ISSN: | 2366-0058 2366-004X |
| DOI: | 10.1007/s00261-015-0562-1 |
| Popis: | Recurrent prostate cancer following primary treatment is common, and the population of men with biochemical recurrence is complex. Conventional management of recurrent prostate cancer involves nontargeted and/or systemic therapies, without defining an individual patient's specific disease. However, recent advances in imaging enable a shift in the management of recurrent prostate cancer to targeted, patient-specific approaches. Specifically, MRI can detect and define local prostate cancer recurrence early in the course of disease, and prostate-specific PET imaging greatly improves nodal staging and can detect previously unknown distant metastases. The significant advances in the imaging of both local and distant tumor recurrences allows for specific selection of treatment options tailored to patients and their disease with less associated morbidity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink